History

2023
  • 09 SSCA101-related MOU execution with KTR(Korea Testing & Research Institute)
  • 04 SGS101 Patent granted in EU
2022
  • 12 Ministry of SMEs and Startup ‘Commendation from minister‘, Dr. Jeong Beom Kim (CEO)
  • 10 SGS101 Patent granted in China, India
  • 08 MOU execution with Max Planck Institute for Molecular Biomedicine and Ruhr-University Bochum
  • 01 Korean society for stem cell research ‘young scientist award’, Dr. Hyuanh Lee (R&D director) 01 SuPine Therapeutics Seoul office establishment
2021
  • 10 SGD101 Successful clinical application in veterinary treatment (4 cases) (Ulsan S animal medical center collaboration)
2020
  • 12 SSC101 Paper published in Biomaterials (Convergence technology of iHep and ECM hydrogel)
  • 10 SGS101 Patent applied and granted in S.Korea
  • 08 SGS101 Patent granted in Japan
  • 02 SGS101 Patent applied in S.Korea, Patent granted in Australia
2019
  • 10 SGS101 Patent granted in S.Korea
  • 05 Swiss + Korea Global Biotech Startup Network shop- Selected for Top 3 Promising Startup
2018
  • 12 Venture company certified
  • 07 Company auxiliary research institute certified from KOITA
  • 05 Hyundai Heavy Industry technology contest excellence award
  • 03 SGS101 International Patents applied (PCT and 7 countries)
  • 02 Presentation to 19th president of Korea (Jae-In Moon)
2017
  • 11 SuPine Therapeutics Established